MedTrace Logo

Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications

NCT04222166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-08-27

No results posted yet for this study

Summary

This registry will assess clinical outcomes following the use of Cryopreserved Amniotic Membrane (CAM) for the treatment of orthopedic and various other conditions. This registry will collect outcomes data via a registry of up to 100 patients who have received treatment with CAM in the post-market setting. Patients will be enrolled from up to five healthcare centers.

Conditions

  • Orthopedic Disorder
  • Wound

Interventions

BIOLOGICAL

CAM

Cryopreserved Amniotic Membrane

Sponsors & Collaborators

  • MED Institute Inc.

    lead INDUSTRY

Principal Investigators

  • Theodore Heise, PhD · MED Institute Inc.

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-16
Primary Completion
2021-06-30
Completion
2021-08-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04222166 on ClinicalTrials.gov